Real-world prescribing trends of valproate in women with epilepsy in Korea
暂无分享,去创建一个
[1] Y. Cho,et al. Treatment of epilepsy in adults: Expert opinion in South Korea , 2020, Epilepsy & Behavior.
[2] D. Thurman,et al. Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy. , 2019, JAMA neurology.
[3] L. Jacob,et al. Trends in valproate use in patients in Germany between 2009 and 2017 , 2019, Epilepsy & Behavior.
[4] S. Bewley,et al. EURAP registry: inadequate monitoring of prescribed drugs in pregnancy , 2018, The Lancet Neurology.
[5] Sean T. Hwang,et al. Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy , 2018, Epilepsy & Behavior.
[6] B. Wettermark,et al. Valproic acid utilization among girls and women in Stockholm: Impact of regulatory restrictions , 2018, Epilepsia open.
[7] T. Tomson,et al. Dose-dependent teratogenicity of valproate in mono- and polytherapy , 2015, Neurology.
[8] K. Meador,et al. Antiepileptic drug use by pregnant women enrolled in Florida Medicaid , 2015, Neurology.
[9] Dong Wook Kim,et al. Clinical characteristics of patients with treated epilepsy in Korea: A nationwide epidemiologic study , 2014, Epilepsia.
[10] Mogens Vestergaard,et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. , 2013, JAMA.
[11] K. Meador,et al. Cognitive and neurodevelopmental effects of antiepileptic drugs , 2011, Epilepsy & Behavior.
[12] W. Hauser,et al. Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes , 2009, Neurology.
[13] K. Meador,et al. Antiepileptic drug use in women of childbearing age , 2009, Epilepsy & Behavior.
[14] K. Meador,et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. , 2009, The New England journal of medicine.
[15] A. Herzog,et al. Sexual hormones and epilepsy: threat and opportunities , 2005, Current opinion in neurology.